
    
      We will use non-invasive phosphorus magnetic resonance spectroscopy technique to measure
      creatine kinase (CK) flux in failing heart. The studies will be done on Siemens 3.0T human
      system. We will recruit subjects with LV dysfunction due to prior anterior wall myocardial
      infarction.
    
  